January 10, 2024
Emyria (ASX:EMD) offers new hope to Australia’s PTSD non-responders
Emyria authorised to prescribe MDMA to treat Australian’s with PTSD.
Category: Pharmaceuticals
September 1, 2023
Paradigm hits the road with new inflammation treatment
Paradigm Biopharmaceutical will feature their injectable PPS for treating osteoarthritis and mucopolysaccharidosis at international conferences.
August 25, 2023
Clarity (ASX:CU6) get clear sight on prostate treatment
A swift recruitment process for its trial escalation shows high demand for better and more accessible prostate cancer therapy.
January 18, 2023
Firebrick (ASX:FRE) gets up the nose of common cold
Firebrick Pharma research has indicated the efficacy of its nasal spray in treating symptoms associated with the common cold.
January 11, 2023
MGC Pharma (ASX:MXC) tackles COVID afterburner
MGC Pharmaceuticals shows encouraging signs for cannabinoid-based COVID treatment.